OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
10.18
-0.30 (-2.86%)
Dec 11, 2025, 1:41 PM EST
OpGen Market Cap
OpGen has a market cap or net worth of $105.55 million as of December 11, 2025. Its market cap has increased by 2,533.83% in one year.
Market Cap
105.55M
Enterprise Value
107.03M
Revenue
9.00M
Ranking
n/a
PE Ratio
27.87
Stock Price
$10.18
Market Cap Chart
Since May 5, 2015, OpGen's market cap has increased from 51.90M to 105.55M, an increase of 103.39%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 105.55M | 1,661.90% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | 45.88M | 1,069.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 558.66M |
| Glass House Brands | 470.56M |
| CytoDyn | 410.11M |
| Northwest Biotherapeutics | 367.17M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 259.91M |